Published in Blood Weekly, June 28th, 2001
The research was conducted at the University of Rochester Medical Center and written up for the June 1, 2001, issue of the journal Blood.
Tested on 34 patients, R115777 was less toxic than traditional chemotherapy. In addition, 30% of the patients who took R115777 went into partial or complete remission.
This result was somewhat unexpected, physicians say; early studies of experimental drugs are designed to assess safety, toxicity, and whether the treatment works the way it was meant to work. It's unusual for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.